V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 290006678 | 290005038 | 1.71 | 108 | Adjuvant (A) | null | 2013-05-14 | CARBOPLATIN + RT | N | N | 290020330 | CYCLOPHOSPHAMIDE + DOCETAXEL |
| 290006679 | 290005039 | null | 95 | Curative (C) | 2017-02-18 | 2017-02-18 | DHAP - R | N | Y | 290020345 | CARBOPLATIN + RT |
| 290006680 | 290005041 | 1.52 | null | Curative (C) | 2016-03-16 | 2016-03-29 | Carboplatin AUC 2 - 5 | N | Y | 290020347 | CARBOPLATIN |
| 290006681 | 290005042 | null | 69 | Palliative (P) | 2017-05-19 | 2017-05-19 | Capecitabine | 02 | N | 290020351 | CAPECITABINE + CARBOPLATIN |
| 290006682 | 290007125 | 1.68 | 97 | Palliative (P) | null | 2013-12-01 | Cetuximab 7 day (>Cycle 2) | 02 | N | 290020352 | CETUXIMAB + IRINOTECAN + MDG |
| 290006683 | 290007964 | null | 78 | Palliative (P) | 2016-12-29 | 2017-01-09 | Sunitinib | 02 | N | 290020355 | NIVOLUMAB |
| 290006684 | 290007126 | 1.52 | null | Curative (C) | null | 2013-11-20 | Capecitabine | null | N | 290020357 | RITUXIMAB |
| 290006685 | 290007126 | 1.75 | 48.9 | Adjuvant (A) | 2016-12-28 | 2017-01-21 | EOX | N | Y | 290020357 | TRASTUZUMAB |
| 290006686 | 290007126 | 1.73 | 55.8 | Adjuvant (A) | 2017-04-21 | 2017-04-21 | Capecitabine + Oxaliplatin 21day | 2 | N | 290020357 | CISPLATIN + RT |
| 290006687 | 290005048 | 1.68 | 88.4 | Adjuvant (A) | 2014-08-11 | 2014-09-21 | REGORAFENIB | N | Y | 290020366 | CAPECITABINE + OXALIPLATIN |
| 290006688 | 290005049 | 1.73 | 55.9 | null | 2016-10-25 | 2017-10-21 | LANREOTIDE | 2 | Y | 290020367 | LANREOTIDE |
| 290006689 | 290005051 | 1.79 | 72 | Adjuvant (A) | 2018-12-03 | 2018-12-24 | Rituximab | N | Y | 290020378 | CETUXIMAB + CISPLATIN + FU |
| 290006690 | 290005057 | 1.58 | 67.8 | Adjuvant (A) | 2017-06-20 | 2018-09-19 | MITOMYCIN | N | N | 290020380 | CAPECITABINE + MITOMYCIN + RT |
| 290006691 | 290005058 | 1.5 | 46.3 | Adjuvant (A) | 2013-06-24 | 2013-06-30 | Doxorubicin chemoembolisation | N | N | 290020385 | CAPECITABINE |
| 290006692 | 290005059 | 1.77 | null | Palliative (P) | 2013-10-07 | 2013-11-04 | FLUOROURACIL + MITOMYCIN | 02 | Y | 290020389 | CISPLATIN + TEYSUNO |
| 290006693 | 290007967 | 1.55 | 64.8 | Palliative (P) | 2014-02-09 | 2014-07-31 | LANREOTIDE | N | Y | 290020391 | CAPECITABINE + CISPLATIN |
| 290006694 | 290008279 | 1.47 | 58.2 | Curative (C) | 2015-01-30 | 2015-01-30 | CISPLATIN + VINORELBINE + RT | 2 | N | 290020392 | CAPECITABINE + MITOMYCIN + RT |
| 290006695 | 290005060 | 1.57 | 68.8 | Curative (C) | 2016-11-19 | 2016-12-10 | INTERAACT trial | N | N | 290020394 | CARBOPLATIN + RT |
| 290006696 | 290005063 | null | 97 | Curative (C) | 2015-07-08 | 2015-07-13 | Cisplatin + Gemcitabine (D 1 & 8) | N | N | 290020400 | CARBOPLATIN + RT |
| 290006697 | 290005065 | 1.63 | null | Adjuvant (A) | 2017-12-02 | 2017-12-16 | CAPECITABINE + OXALIPLATIN | N | N | 290020404 | CAPECITABINE |
| 290006698 | 290005065 | 1.8 | 68.4 | Curative (C) | 2017-11-01 | 2017-11-01 | OCTREOTIDE | 02 | Y | 290020404 | CHOP R |
| 290006699 | 290007968 | 1.9 | 103.2 | Curative (C) | 2017-03-18 | 2017-03-29 | Capecitabine + Cisplatin | 02 | N | 290020415 | CARBOPLATIN |
| 290006700 | 290007968 | 1.79 | 74.1 | Palliative (P) | 2017-03-06 | 2017-04-15 | Capecitabine + Cisplatin | N | N | 290020415 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 290006701 | 290005066 | 1.6 | 57.7 | Curative (C) | 2002-09-16 | 2015-07-29 | Docetaxel 100mg/m2 (21 day) | 02 | N | 290020421 | CISPLATIN |
| 290006702 | 290005068 | 1.74 | 62.6 | Curative (C) | 2017-06-07 | 2017-06-21 | Capecitabine + Mitomycin | N | N | 290020421 | CARBOPLATIN + RT |
| 290006703 | 290005071 | 1.73 | 92 | Palliative (P) | 2015-05-15 | 2015-07-01 | CAPECITABINE + OXALIPLATIN | 2 | N | 290020427 | SUNITINIB |
| 290006704 | 290005071 | 1.57 | 77 | Curative (C) | 2014-03-16 | 2014-03-17 | Capecitabine | 02 | N | 290020427 | CISPLATIN + RT |
| 290006705 | 290005071 | 1.69 | null | null | 2015-10-19 | 2015-10-19 | Capecitabine + Oxaliplatin 21day | N | Y | 290020427 | LANREOTIDE |
| 290006706 | 290005072 | 1.64 | 64.2 | Curative (C) | 2017-03-08 | 2017-03-08 | CARBOPLATIN + RT | 02 | N | 290020443 | CISPLATIN + RT |
| 290006707 | 290005072 | null | 82 | Adjuvant (A) | 2015-01-12 | 2015-02-26 | FEC 60 or 75 | N | N | 290020443 | CARBOPLATIN + RT |
| 290006708 | 290005073 | 1.66 | null | Palliative (P) | 2013-08-13 | 2013-09-02 | Cetuximab + Oxaliplatin + MdG Maint | 02 | N | 290020447 | CARBOPLATIN + ETOPOSIDE |
| 290006709 | 290005074 | 1.68 | 93 | Curative (C) | 2015-09-16 | 2015-09-17 | INTERAACT trial | 02 | N | 290020449 | RITUXIMAB |
| 290006710 | 290005077 | 0 | 63.2 | Palliative (P) | 2016-12-16 | 2016-12-21 | CISPLATIN + RT | N | Y | 290020461 | REGORAFENIB |
| 290006711 | 290005078 | 1.7 | 84.6 | null | 2018-01-28 | 2018-01-28 | Cisplatin | N | N | 290020463 | CETUXIMAB + RT |
| 290006712 | 290005078 | 1.69 | 56.3 | Curative (C) | 2017-09-17 | 2017-10-09 | PEMBROLIZUMAB | 2 | N | 290020463 | RITUXIMAB |
| 290006713 | 290005078 | 1.47 | 67.55 | Curative (C) | 2016-10-21 | 2016-11-13 | Brentuximab Vedotin | 2 | N | 290020463 | CISPLATIN + RT |
| 290006714 | 290005079 | 1.9 | null | Curative (C) | 2018-10-17 | 2018-11-11 | Y-90 | null | N | 290020475 | METHOTREXATE INTRATHECAL |
| 290006716 | 290005080 | 1.9 | 53.2 | Curative (C) | 2017-03-17 | 2017-03-29 | null | N | N | 290020492 | R CODOX M |
| 290006717 | 290005080 | 0 | 77.7 | null | 2014-09-28 | 2014-10-20 | Gemcitabine weekly | 02 | null | 290020492 | LANREOTIDE |
| 290006718 | 290005081 | 1.81 | 52.6 | Palliative (P) | 2015-05-20 | 2016-09-19 | Fluorouracil PVI + Mitomycin 42 day | N | null | 290020503 | CAPECITABINE + OXALIPLATIN |
| 290006719 | 290005084 | null | 82 | null | 2018-02-01 | 2018-02-01 | Capecitabine | N | N | 290020519 | LANREOTIDE |
| 290006720 | 290005084 | 1.82 | 55 | Neo-adjuvant (N) | 2015-02-06 | 2015-02-06 | Cabazitaxel | 02 | N | 290020519 | CAPECITABINE + RT |
| 290006721 | 290005085 | 1.95 | 56 | Palliative (P) | 2017-12-16 | 2017-12-16 | MITOMYCIN | N | Y | 290020539 | PACLITAXEL |
| 290006722 | 290005086 | 1.82 | 58.9 | Curative (C) | 2018-01-14 | 2018-01-17 | CETUXIMAB | N | N | 290020541 | CISPLATIN + RT |
| 290006723 | 290005087 | 1.72 | 60 | Curative (C) | 2017-01-01 | 2017-01-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 290020542 | CAPECITABINE + OXALIPLATIN |
| 290006724 | 290005088 | 1.71 | null | Curative (C) | 2017-11-06 | 2017-11-11 | EOX | null | Y | 290020542 | CISPLATIN |
| 290006725 | 290005088 | 1.63 | 56 | Palliative (P) | 2016-08-26 | 2016-08-27 | CETUXIMAB | 02 | N | 290020542 | CAPECITABINE + OXALIPLATIN |
| 290006726 | 290005092 | null | null | Palliative (P) | null | 2014-09-06 | Capecitabine + Mitomycin | null | null | 290020552 | CAPECITABINE + IRINOTECAN |
| 290006727 | 290005092 | 1.49 | null | Neo-adjuvant (N) | 2015-08-17 | 2015-08-17 | REGORAFENIB | 02 | N | 290020552 | NOT MATCHED |
| 290006728 | 290005093 | null | 72.4 | Palliative (P) | 2016-12-19 | 2016-12-19 | Trabectedin | null | N | 290020555 | CAPECITABINE + CISPLATIN |